Evofem Biosciences Posts Corporate Presentation for Investor Community

Evofem Biosciences, Inc. filed a Form 8-K on July 20, 2026, to disclose that the company is posting its current corporate slide presentation to the investors section of its website. The filing indicates that Evofem periodically presents and distributes these slides at various industry and investment conferences to provide business updates and summaries. The corporate presentation, prepared as of July 20, 2026, is attached as Exhibit 99.1 to the filing. The company specifically notes that it undertakes no obligation to update, supplement, or amend the materials attached as Exhibit 99.1. The disclosure is made under Regulation FD (Fair Disclosure) requirements, and the company clarifies that the information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act, nor shall it be deemed incorporated by reference in any filing under the Securities Act or Exchange Act, except as expressly set forth by specific reference.